Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents

JACC: Cardiovascular Interventions

Volumn 4, Issue 10, 2011, Pages 1067-1074

  Collet, Carlos A ^a   Costa, J Ribamar ^a   Abizaid, Alexandre ^a   Chamié, Daniel ^a   Staico, Rodolfo ^a   Costa, Ricardo ^a   Siquera, Dimytri ^a   Obregon, Javier ^a   Feres, Fausto ^a   Sousa, Amanda ^a   Sousa, Jose Eduardo ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

drug eluting stents; intravascular ultrasound; neointimal hyperplasia

Indexed keywords

CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE; UMIROLIMUS;

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTRAVASCULAR ULTRASOUND; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOINTIMA; RISK FACTORS; SIROLIMUS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC; TICLOPIDINE; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 80055022997     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.07.010     Document Type: Article

References (30)

1. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
2. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
3. R.A. Byrne, A. Kastrati, K. Tiroch ISAR-TEST-2 Investigators 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor drug-eluting stents J Am Coll Cardiol 55 2010 2536 2543
4. S.J. Kang, D.W. Park, and G.S. Mintz Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis Am J Cardiol 105 2010 1402 1408
5. R.A. Byrne, R. Iijima, and J. Mehilli Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer J Am Coll Cardiol Intv 2 2009 291 299
6. K.W. Park, C.H. Kim, and H.Y. Lee Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents Am Heart J 159 2010 44653.e3
7. J.E. Sousa, M.A. Costa, and A.S. Abizaid Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 103 2001 192 195 (Pubitemid 32095401)
8. E. Grube, K.E. Hauptmann, L. Buellesfeld, V. Lim, and A. Abizaid Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating EuroIntervention 1 2005 53 57
9. S.G. Ellis, M.G. Vandormael, M.J. Cowley Multivessel Angioplasty Prognosis Study Group Coronary morphologic and clinical determinates of procedural outcome with angioplasty for multivessel coronary disease Implications for patient selection Circulation 82 1990 1193 1202
10. G.S. Mintz, S.E. Nissen, and W.D. Anderson American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS) A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 37 2001 1478 1492
11. J. Ako, Y. Morino, and Y. Honda Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis J Am Coll Cardiol 46 2005 1002 1005 (Pubitemid 41316506)
12. G. Nakazawa, A.V. Finn, M. Vorpahl, E.R. Ladich, F.D. Kolodgie, and R. Virmani Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents J Am Coll Cardiol 57 2011 390 398
13. A.J. Carter, M. Aggarwal, and G.A. Kopia Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovasc Res 63 2004 617 624 (Pubitemid 39078675)
14. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
15. M.C. John, R. Wessely, and A. Kastrati Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents J Am Coll Cardiol Intv 1 2008 535 544
16. W.J. van der Giessen, A.M. Lincoff, and R.S. Schwartz Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697 (Pubitemid 26320276)
17. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 2011 779 797
18. R.A. Byrne, A. Kastrati, and K. Tiroch Two-year clinical and angiographic outcomes from a stratified randomized controlled trial of everolimus-eluting Xience stents versus sirolimus-eluting Cypher stents in patients with coronary artery disease enrolled in the ISAR-TEST-4 trial Presented at: Transcatheter Cardiovascular Therapeutics Washington, DC September 2125, 2010
19. N. Kuriyama, Y. Kobayashi, and T. Nakama Late restenosis following sirolimus-eluting stent implantation J Am Coll Cardiol Intv 4 2011 123 128
20. D.W. Park, M.K. Hong, and G.S. Mintz Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study J Am Coll Cardiol 48 2006 2432 2439 (Pubitemid 44881217)
21. Y. Nakagawa, T. Kimura, T. Morimoto j-Cypher Registry Investigators Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336
22. K. Yamaji, T. Kimura, and T. Morimoto Very long-term (15 to 20 years) clinical and angiographic outcome after coronary bare metal stent implantation Circ Cardiovasc Interv 3 2010 468 475
23. A. Caixeta, M.B. Leon, and A.J. Lansky 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents J Am Coll Cardiol 54 2009 894 902
24. E. Grube, K. Dawkins, and G. Guagliumi TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions Euro Intervention 4 2009 572 577
25. S.G. Ellis, G.W. Stone, D.A. Cox TAXUS IV Investigators Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent) J Am Coll Cardiol Intv 2 2009 1248 1259
26. A. Caixeta, A. Lansky, P.W. Serruys SPIRIT II and III Investigators Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials J Am Coll Cardiol Intv 3 2010 1220 1228
27. P.W. Serruys, P. Buszman, and A. Linke A prospective, randomised, non-inferiority trial comparing biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer: 3-year clinical follow-up Presented at: Transcatheter Cardiovascular Therapeutics Washington, DC September 2125, 2010
28. L. Mauri, J.M. Massaro, and S. Jiang Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents J Am Coll Cardiol Intv 3 2010 1240 1249
29. G. Weisz, M.B. Leon, and D.R. Holmes Jr. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial J Am Coll Cardiol 53 2009 1488 1497
30. M. Takano, M. Yamamoto, and M. Mizuno Late vascular responses from 2 to 4 years after implantation of sirolimus-eluting stents: serial observations by intracoronary optical coherence tomography Circ Cardiovasc Interv 3 2010 476 483